Xiaoling Zhang

发表

Nivolumab plus ipilimumab in advanced melanoma.

C. Horak, J. Wolchok, M. Sznol, 2013, The New England journal of medicine.

Plasma-based early screening and monitoring of EGFR mutations in NSCLC patients by a 3-color digital PCR assay

Xiaoling Zhang, L. Chu, Xiaoyan Feng, 2020, British Journal of Cancer.

Association between EGFR/KRAS mutation and expression of VEGFA, VEGFR and VEGFR2 in lung adenocarcinoma

Xiaoling Zhang, Jie Yang, Ting-ting Qin, 2018, Oncology letters.

Association of tumor PD-L1 expression and immune biomarkers with clinical activity in patients (pts) with advanced solid tumors treated with nivolumab (anti-PD-1; BMS-936558; ONO-4538).

Clive R. Taylor, J. Taube, C. Horak, 2013 .

Programmed death-ligand 1 (PD-L1) expression in various tumor types

Xiaoling Zhang, J. Cogswell, J. Grosso, 2013, Journal of Immunotherapy for Cancer.

Efficacy and safety of apatinib alone or apatinib plus paclitaxel/docetaxel versus paclitaxel/docetaxel in the treatment of advanced non‐small cell lung cancer: A meta‐analysis

Z. Li, Xiaoling Zhang, Zhibao Liu, 2021, Thoracic cancer.

Safety and efficacy of mutant neoantigen-specific T-cell treatment combined anti-PD-1 therapy in stage IV solid tumors.

X. Yi, Xiaoling Zhang, Dan Wang, 2022, Immunotherapy.

Development of an Automated PD-L1 Immunohistochemistry (IHC) Assay for Non–Small Cell Lung Cancer

Xiaoling Zhang, H. Inzunza, J. Cogswell, 2015, Applied immunohistochemistry & molecular morphology : AIMM.

Development of a Diagnostic Programmed Cell Death 1-Ligand 1 Immunohistochemistry Assay for Nivolumab Therapy in Melanoma

Clive Taylor, Henrik Winther, Xiaoling Zhang, 2017, Applied immunohistochemistry & molecular morphology : AIMM.

Bevacizumab promotes active biological behaviors of human umbilical vein endothelial cells by activating TGFβ1 pathways via off-VEGF signaling

Xiaoling Zhang, Tingting Qin, Cui-cui Zhang, 2020, Cancer biology & medicine.

Tumor necrosis factor superfamily 15 promotes lymphatic metastasis via upregulation of vascular endothelial growth factor‐C in a mouse model of lung cancer

Xiaoling Zhang, Tingting Qin, C. Xian, 2018, Cancer science.

Prognostic and predictive value of plasma d-dimer levels in patients with small-cell lung cancer

Xiaoling Zhang, Yongsheng Jia, Cui-cui Zhang, 2018, International Journal of Clinical Oncology.

The Efficacy and Safety of Anlotinib Combined With PD-1 Antibody for Third-Line or Further-Line Treatment of Patients With Advanced Non-Small-Cell Lung Cancer

Xiaoling Zhang, H. Pan, Qin Pan, 2021, Frontiers in Oncology.

CD31‐labeled circulating endothelial cells as predictor in anlotinib‐treated non‐small‐cell lung cancer: Analysis on ALTER‐0303 study

Li Lin, Xiaoling Zhang, Tingting Qin, 2018, Cancer medicine.